Pfizer: Corona Vaccine Also Works in Children Over 12 Years Old
Pfizer and BioNTech report that their corona vaccine is safe and effective in studying the drug on 12-15-year-olds.
The group that received the vaccine did not become infected with the coronavirus.
The study involved 2,260 children in the United States. Half received the vaccine, the other half a placebo. Eighteen infections were found in the last group. The vaccinated children did not develop an infection, which the companies say shows that their vaccine is 100 percent effective in this age group.
It is also reported that the children could tolerate the vaccine well, and the side effects were consistent with those of the 16 to 25 years age group. After vaccination with the Pfizer / BioNTech product, vaccinees may experience headaches, muscle pain, fatigue and chills, among other things.
The companies further report that the vaccinated children had a similar number of antibodies one month after the second dose compared to subjects in the 16 to 25-year-old group. The children are followed for two more years after their second shot to monitor the vaccine’s long-term effects.
Pfizer and BioNTech plan to send the data to the European Medicines Agency (EMA) and the US Medicines Regulator (FDA) as soon as possible. The vaccine can also be used in children from the age of 12. The vaccine is now only approved for people over the age of 16.
In practice, the Pfizer / BioNTech vaccine is only administered to adults. That’s not only because of the age group for which it is approved but also because of the scarcity of vaccines. The two companies are also currently testing the vaccine on younger children. The youngest participants in the study will be 6 months old.